ArticlePolymers2026
Qualification of a Swellable Hydrogel-Silicone Bimorph for Implantable Actuation.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To improve the structural adaptability and biological suitability of cochlear implant electrode carriers, this study systematically develops and evaluates novel 3D-printed, swellable hydrogel-silicone composites. A vinylphosphonic acid-acrylamide hydrogel powder (VPA-AAm) was pre-washed, milled, and sieved, incorporated into a silicone matrix, and 3D-printed before rapid thermal curing, followed by microstructural, swelling, and in vitro WST-1 cytotoxicity analyses. Pre-washing minimized particle agglomeration and facilitated high-resolution printing. Incorporating the hydrogel induced complete macroscopic opacity at 25 wt.% and localized microporosity during rapid thermal curing. The non-percolating morphology influenced swelling and mass transport through the composite, providing a mechanistic link between water uptake and the observed cell-viability response. While a 35 wt.% loading was associated with matrix degradation and cell viability below the 70% threshold, the 30 wt.% composition achieved the highest water absorption of approximately 400-460%, consistent with a favorable balance between osmotic swelling and matrix elasticity. This swelling behavior was associated with controlled release characteristics and non-cytotoxic extract responses at intermediate hydrogel loading. Consequently, the 30 wt.% composite represents a promising material combination for implantable medical devices, balancing swelling performance, structural stability, and favorable in vitro cell viability under the investigated extraction conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.